Accounts Receivable, after Allowance for Credit Loss, Current in USD of GeneDx Holdings Corp. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
GeneDx Holdings Corp. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and change rate from Q4 2020 to Q3 2025.
  • GeneDx Holdings Corp. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Sep 2025 was $60.9M.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

GeneDx Holdings Corp. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $60.9M 30 Sep 2025 10-Q 28 Oct 2025
Q2 2025 $48M 30 Jun 2025 10-Q 29 Jul 2025
Q1 2025 $46M 31 Mar 2025 10-Q 30 Apr 2025
Q4 2024 $37.6M 31 Dec 2024 10-Q 28 Oct 2025
Q1 2023 $32.9M -$4.73M -12.6% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 $42.6M +$16.1M +60.8% 31 Dec 2022 10-Q 09 May 2023
Q3 2022 $42.7M +$21.4M +101% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $45.8M +$21.2M +86.4% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $37.6M +$4.3M +12.9% 31 Mar 2022 10-Q 12 May 2022
Q4 2021 $26.5M -$5.54M -17.3% 31 Dec 2021 10-K 16 Mar 2023
Q3 2021 $21.3M 30 Sep 2021 10-K 14 Mar 2022
Q2 2021 $24.6M 30 Jun 2021 10-K 14 Mar 2022
Q1 2021 $33.3M 31 Mar 2021 10-K 14 Mar 2022
Q4 2020 $32M 31 Dec 2020 10-K 14 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.